Expert Opinion on Pharmacotherapy
Investigating oral blarcamesine for treatment of early Alzheimer's disease
ReviewInterventions
Papers by Marwan N. Sabbagh
18 results
- Alzheimer's & Dementia
Management of multimorbidity in the midst of cognitive decline through clinical decision-support software
Cross-sectional study of 17,915 peoplePopulations
- AAIC 2025 Abstract
Photobiomodulation: A Promising Safe Therapy for Alzheimer's Disease
ReviewInterventions - AAIC 2025 Abstract
Blood‐Based Biomarkers in the Lecanemab Patient Pathway for Early Alzheimer’s Disease in the United States
Study in peopleBiomarkers - AAIC 2025 Abstract
Real‐World Insights on the Lecanemab Patient Pathway in Early Alzheimer’s Disease in the United States
Study in peoplePopulations - AAIC 2025 Abstract
Real‐World Use of Lecanemab in APOE ε4 Homozygotes and in Patients on Antithrombotic Therapy
Study in peopleInterventions - AAIC 2025 Abstract
Real‐World Use of Lecanemab With Consideration of Race, Ethnicity, and Geographical Diversity
Study in peoplePopulations - AAIC 2025 Abstract
Real‐World Use of Lecanemab in Patients With Early Alzheimer’s Disease in the United States: a Case Series Review
Study in peopleInterventions - AAIC 2025 Abstract
Indirect Treatment Comparison of ARIA Outcomes for Lecanemab Compared to Donanemab Based on Reported Results
Computational studyInterventions